LUMBAR DISC HERNIATION
The current study is a Phase 3, multicenter, randomized, double-blind, sham-controlled,
comparative study of SI-6603 in subjects with LDH. Subjects will receive a single intradiscal
dose of SI-6603 1.25 U or a sham injection as control. Safety will be followed for 12 months
after investigational product administration.
Do you Qualify?
These questions require a yes answer to qualify.
Are you between 30 and 70 years of age?
Are you experiencing leg pain caused by the herniation?
These questions require a no answer to qualify.
Are you currently pregnant, plan to become pregnant or breastfeeding?
Currently suffering from any major illnesses that may require extended hospitalization?
In the past year have you suffered with any chronic drug or alcohol abuse?
If you think you may be eligible for this trial, please give us a call to schedule an appointment or click button below to email a request.